In September 2022, the US Food and Drug Administration (FDA) approved Sotyktu (deucravacitinib; Bristol-Myers Squibb Company), a tyrosine kinase 2 (TYK2) inhibitor, for the treatment of moderate to ...

An 18-year-old woman presents with a 7-year history of moderate to severe chronic plaque psoriasis involving her scalp, trunk, bilateral upper and lower extremities, and nails. Her chief complaint was ...

Add Yahoo as a preferred source to see more of our stories on Google. If you’ve struggled with itchy, irritated skin, you’ve probably sought out various creams, lotions or ointments to treat it. But ...

Although some people with plaque psoriasis can control their symptoms by using topical treatments that are applied to the skin, some people with moderate or severe plaque psoriasis do not get enough ...

Otezla (apremilast) is an oral tablet commonly used to treat plaque psoriasis in adults and children. Plaque psoriasis is an inflammatory skin condition that causes itchy, painful patches on the skin.

According to our expert, Dr Passi, understanding these differences helps in early identification and choosing the right treatment approach, while also reducing the risk of complications such as ...

The National Psoriasis Foundation has issued a statement that endorses consideration of adjunctive GLP-1 receptor agonists in ...

European regulators have recommended expanding use of the IL-23 inhibitor Skyrizi to treat moderate-to-severe plaque psoriasis in children aged 6 years or older who require systemic therapy.

A recent study published in the journal of Dermatology and Therapy found Tildrakizumab to significantly improve disease ...

Castor oil may help soothe psoriasis symptoms due to its moisturizing and anti-inflammatory properties. Types of castor oil ...